Endocrine & Metabolic Disorders

Advanced treatments for hormonal and metabolic conditions improving patient quality of life

Endocrine Innovation

Oracle BioTech develops breakthrough therapies for endocrine and metabolic disorders, addressing diabetes, thyroid conditions, and rare metabolic diseases with precision medicine approaches.

Diabetes Technology

Diabetes Management

Next-generation insulin therapies and glucose monitoring technologies for improved diabetes control and patient convenience.

  • Long-acting insulin formulations
  • Continuous glucose monitoring
  • Smart insulin delivery systems
  • Type 1 diabetes immunotherapy
Learn More
Metabolic Research

Thyroid & Metabolic Diseases

Innovative treatments for thyroid disorders, obesity, and rare metabolic conditions with improved efficacy and safety profiles.

  • Thyroid hormone replacement
  • Anti-obesity medications
  • Lipid metabolism disorders
  • Growth hormone deficiencies
Learn More

Endocrine Development Pipeline

Discovery

6 Programs

Novel hormone receptor targets and metabolic pathways.

Preclinical

4 Programs

Metabolic disease models and safety assessment.

Phase I

3 Programs

First-in-human diabetes and thyroid studies.

Phase II

2 Programs

Efficacy studies in diabetic patients.

Phase III

1 Program

Pivotal trial for novel insulin therapy.